
- Oncology NEWS International Vol 9 No 11
- Volume 9
- Issue 11
Joe & Ali Torre Lead ‘Two Against One’ Prostate Cancer Campaign
NEW YORK-To help support spouses of prostate cancer patients, New York Yankees manager Joe Torre, a prostate cancer survivor, and his wife Ali are helping to launch “Two Against One: Couples Battling Prostate Cancer.” This multimedia program helps spouses become more informed about prostate cancer and empowers them to advocate for improved outcomes for their husbands.
NEW YORKTo help support spouses of prostate cancer patients, New York Yankees manager Joe Torre, a prostate cancer survivor, and his wife Ali are helping to launch Two Against One: Couples Battling Prostate Cancer. This multimedia program helps spouses become more informed about prostate cancer and empowers them to advocate for improved outcomes for their husbands.
The program was developed with the prostate cancer advocacy group US TOO! International, Inc., the American Foundation for Urologic Disease, and an alliance of prominent medical urologists and oncologists. Biotechnology companies Amgen and Praecis Pharmaceuticals are sponsoring the program.
The physical effects of prostate cancer may strike only men, but research shows that the emotional impact of the disease can be even greater for their wives.
That doesnt stop wives from playing a key role in their husbands prostate cancer careapproximately one in four men with prostate cancer say their treatment decision was made either solely by their wife/partner or equally with them, according to results of a national survey by Roper Starch Worldwide.
The new Two Against One program consists of a website that leads spouses through the trauma of diagnosis, treatment, and beyond. It also features links to other useful resources. This information has been captured in a free printed booklet.
Also available is a new educational video, Not By Myself, featuring singers Billy Davis, Jr., and Marilyn McCoo, another famous couple that has successfully faced prostate cancer.
The booklet and video are available by calling toll-free 877-550-9624. The Two Against One website is found at
Articles in this issue
almost 25 years ago
Efforts to Reduce Tobacco Deaths May Fail in the Short Termalmost 25 years ago
Data Published for First-Line Irinotecanalmost 25 years ago
Manufacturing Capability a Factor in Success of New Biologicsalmost 25 years ago
Report Finds States Not Using Tobacco Funds for Preventionalmost 25 years ago
NCI Intramural Program Challenged to ‘Reinvent Itself’almost 25 years ago
Surgery Supported for Recurring Colorectal Canceralmost 25 years ago
Breast Cancer Stamp Funds $6.7 Million in 2-Year NCI Grantsalmost 25 years ago
Human Side of Cancer Offers Insights on Coping With the Diseasealmost 25 years ago
Irinotecan/Etoposide Combination Achieves 65% Overall Response RateNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.